| 1 |
34922249 | Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway. | 2022 Feb |
2 |
| 2 |
35512032 | Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis. | 2022 May 5 |
3 |
| 3 |
34013490 | Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models. | 2021 Oct |
1 |
| 4 |
32152798 | Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway. | 2020 Apr |
1 |
| 5 |
31781591 | Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-κB Signaling Pathways. | 2019 |
6 |
| 6 |
29383139 | Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway. | 2017 Dec 29 |
4 |
| 7 |
23429041 | Inhibitory effect of dihydroartemisinin against phorbol ester-induced cyclooxygenase-2 expression in macrophages. | 2013 Jun |
3 |